Solutions for Life Science & Diagnostics
Anti-SLC2A1/GLUT1 polyclonal antibody Trial size
Additional Information
Anti-SLC2A1/GLUT1 polyclonal antibody Trial size Specifications
| Background: | Glucose transporters (GLUT) are integral membrane glycoproteins involved in transporting glucose into most cells. SLC2A1/GLUT1 facilitates glucose transport across the blood brain barrier. Functional defects of SLC2A1 cause autosomal dominant GLUT1 deficiency syndrome, which are characterized by infantile seizures, delayed development, hypoglucorrhachia, and acquired microcephaly. |
| Clonality: | Polyclonal |
| Gene ID Human: | 6513 |
| Gene ID Mouse: | 20525 |
| Host Species: | Rabbit |
| Regulatory Statement: | For Research Use Only. Not for use in diagnostic procedures. |
| Isotype: | IgG |
| Product Type: | Primary Antibody |
| Reactivity: | This antibody can be used to stain endogenous antigen in paraffin embedded human tissues including bladder and stomach by immunohistochemistry. The reactivity of this antibody has been confirmed by Western blotting to detect the full-length of human SLC2A |
| Shipping: | 4 |
| Size: | 10μL |
| Source: | This antibody was affinity purified from rabbit serum. The rabbit was immunized with a synthetic peptide derived from human SLC2A1. |
| Status: | RUO |
| Storage: | -20 |
| Target: | SLC2A1/GLUT1 |
Applications:
There are no additional documents for Anti-SLC2A1/GLUT1 polyclonal antibody Trial size at this time.
1) Wang, D., et al., Ann. Neurol. 57, 111-118 (2005) 2) Seidner, G., et al., Nat. Genet. 18, 188-191 (1998) 3) Agus, D. B., et al., J. Clin. Invest. 100, 2842-2848 (1997)
